Sponsor or institution

Clinical trials and research at Shionogi Inc.

• 7Clinical trials
• 20Countries

Newest trials

All recruiting trials (7)

• Secutrelvir for nonhospitalized COVID-19 in teens and adults

  This study tests whether secutrelvir can help nonhospitalized people with COVID-19 see faster symptom relief compared with a placebo.

  Recruiting Phase 3 Shionogi Inc. · Multiple Locations · NCT07746544

• Secutrelvir for high-risk COVID-19 patients who are not in hospital

  This study tests whether secutrelvir can help nonhospitalized teens and adults with COVID-19 who are at high risk of getting worse.

  Recruiting at 38 sites Phase 3 Shionogi Inc. · Coral Gables, Florida and 50 other locations · NCT07743580

• S-337395 for high-risk adults with symptomatic RSV

  This trial will test whether taking the antiviral S-337395 within 72 hours of symptoms helps nonhospitalized adults with RSV who are at high risk of progressing to severe illness.

  Recruiting at 88 sites Phase 2 Shionogi Inc. · Los Angeles, California and 88 other locations · NCT07214571

• S-606001 added to enzyme replacement therapy for adults with late-onset Pompe disease

  This trial tests whether adding S-606001 to ongoing enzyme replacement therapy is safe and can improve walking distance and breathing in adults with late-onset Pompe disease.

  Recruiting at 27 sites Phase 2 Shionogi Inc. · Irvine, California and 27 other locations · NCT07123155

• S-892216 long-acting injectable for healthy adults

  This trial will test single and multiple doses of the long-acting injectable S-892216 for safety and to see how the body processes it in healthy adults.

  Recruiting Phase 1 Shionogi Inc. · Cypress, California and 2 other locations · NCT07093580

• Evaluating the safety and effects of naldemedine in children using opioids

  This study is testing whether a new medication called naldemedine can help children who are using opioids for pain avoid constipation and stay safe while doing so.

  Recruiting at 4 sites Phase 1/2 Shionogi Inc. · Tirana and 15 other locations · NCT05588323

• Testing S-531011 alone and with an immune therapy for advanced solid tumors

  This study is testing a new treatment called S-531011, both alone and with an immune therapy, to see if it can help people with advanced solid tumors that haven't responded to other treatments.

  Recruiting at 6 sites Phase 1/2 Shionogi Inc. · Los Angeles, California and 7 other locations · NCT05101070

Quick answers

How many clinical trials run by Shionogi Inc. are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 20 countries. The most sites are in Japan (5 trials), United States (5 trials), Belgium (2 trials), France (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 3: 2, Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →